naphazoline has been researched along with Disease Exacerbation in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, S | 1 |
| Ciprandi, G | 1 |
| Pistorio, A | 1 |
| Tosca, M | 1 |
| Cirillo, I | 1 |
1 review available for naphazoline and Disease Exacerbation
| Article | Year |
|---|---|
[Treatment of pure ocular myasthenia: a proposal from Japan MG registry 2012].
Topics: Blepharoptosis; Calcineurin Inhibitors; Cholinesterase Inhibitors; Diplopia; Disease Progression; Hu | 2013 |
1 other study available for naphazoline and Disease Exacerbation
| Article | Year |
|---|---|
Relationship between rhinitis duration and response to nasal decongestion test.
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Adult; Asthma; Disease Progression; Female; H | 2008 |